Thiostrepton suppresses rhabdomyosarcoma progression by targeting the PI3K–AKT pathway Post author:admin Post published:October 30, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like New machine learning model improves accuracy of prenatal genetic testing August 11, 2026 New study shows age, sex, race crucial for predicting mortality risks in older adults May 5, 2024 Comprehensive BMJ review identifies most effective bipolar disorder treatments August 11, 2026